Alternative splicing of neurofibromatosis type 1 gene transcript in malignant brain tumors: PCR analysis of frozen-section mRNA

1992 ◽  
Vol 6 (2) ◽  
pp. 83-87 ◽  
Author(s):  
Hiroshi Mochizuki ◽  
Toru Nishi ◽  
Janet M. Bruner ◽  
Polly S. Y. Lee ◽  
Victor A. Levin ◽  
...  
Keyword(s):  
Alternative Splicing ◽  
Brain Tumors ◽  
Neurofibromatosis Type 1 ◽  
Frozen Section ◽  
Neurofibromatosis Type ◽  
Pcr Analysis ◽  
Gene Transcript ◽  
Malignant Brain Tumors

scholarly journals Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice

2017 ◽  
Vol 26 (19) ◽  
pp. 3797-3807 ◽  
Author(s):  
Hieu T. Nguyen ◽  
Melissa N. Hinman ◽  
Xuan Guo ◽  
Alok Sharma ◽  
Hiroyuki Arakawa ◽  
...  
Keyword(s):  
Alternative Splicing ◽  
Neurofibromatosis Type 1 ◽  
Neurofibromatosis Type ◽  
Erk Signaling ◽  
Learning Behaviors

Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1

2016 ◽  
Vol 31 (14) ◽  
pp. 1540-1545 ◽  
Author(s):  
Stephanie M. Morris ◽  
Courtney L. Monroe ◽  
David H. Gutmann
Keyword(s):  
Prognostic Factor ◽  
Brain Tumors ◽  
Clinical Features ◽  
Neurofibromatosis Type 1 ◽  
Neurofibromatosis Type ◽  
Optic Pathway Glioma ◽  
Optic Pathway ◽  
Clinical Progression ◽  
Clinical Biomarkers

Neurofibromatosis type 1 is a common neurogenetic disorder characterized by significant clinical variability. As such, numerous studies have focused on identifying clinical, radiographic, or molecular biomarkers that predict the occurrence or progression of specific clinical features in individuals with neurofibromatosis type 1. One of these clinical biomarkers, macrocephaly, has been proposed as a prognostic factor for optic pathway glioma development. In the current study, the authors demonstrate that macrocephaly is not associated with the development of these brain tumors or the need to institute treatment for clinical progression. These findings suggest that macrocephaly is not a robust biomarker of optic pathway glioma formation or progression in children with neurofibromatosis type 1.

Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene

1998 ◽  
Vol 103 (4) ◽  
pp. 382-385 ◽  
Author(s):  
V. M. Park ◽  
Kathleen A. Kenwright ◽  
Dawn B. Sturtevant ◽  
Enikö Kármá Pivnick
Keyword(s):  
Alternative Splicing ◽  
Neurofibromatosis Type 1 ◽  
Neurofibromatosis Type

Abstract 1295: The association between asthma and pediatric brain tumors in neurofibromatosis type 1

2014 ◽  
Author(s):  
Kimberly J. Johnson ◽  
Nancy Mueller ◽  
Evelyn Sharkey ◽  
Qian Liu ◽  
David H. Gutmann
Keyword(s):  
Brain Tumors ◽  
Neurofibromatosis Type 1 ◽  
Neurofibromatosis Type ◽  
Pediatric Brain Tumors ◽  
Pediatric Brain

scholarly journals EPID-18THE ASSOCIATION BETWEEN ALLERGIC CONDITIONS AND PEDIATRIC BRAIN TUMORS IN NEUROFIBROMATOSIS TYPE 1

2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v81.5-v82
Author(s):  
Kimberly Johnson ◽  
Bree Porcelli ◽  
Nancy Zoellner ◽  
Salmafatima Abadin ◽  
David Gutmann
Keyword(s):  
Brain Tumors ◽  
Neurofibromatosis Type 1 ◽  
Neurofibromatosis Type ◽  
Pediatric Brain Tumors ◽  
Pediatric Brain
Sign in / Sign up

Export Citation Format

Share Document